{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:47:24Z","timestamp":1788583644340,"version":"build-2803163510"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Cryptogenic sensory peripheral neuropathy (CSPN) is highly prevalent and often disabling due to neuropathic pain. Metabolic syndrome and its components increase neuropathy risk. Diet and exercise have shown promise but are limited by poor adherence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine whether topiramate can slow decline in intraepidermal nerve fiber density (IENFD) and\/or neuropathy-specific quality of life measured using the Norfolk Quality of Life\u2013Diabetic Neuropathy (NQOL-DN) scale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>Topiramate as a Disease-Modifying Therapy for CSPN (TopCSPN) was a double-blind, placebo-controlled, randomized clinical trial conducted between February 2018 and October 2021. TopCSPN was performed at 20 sites in the National Institutes of Health\u2013funded Network for Excellence in Neurosciences Clinical Trials (NeuroNEXT). Individuals with CSPN and metabolic syndrome aged 18 to 80 years were screened and randomly assigned by body mass index (&amp;amp;lt;30 vs \u226530), which is calculated as weight in kilograms divided by height in meters squared. Patients were excluded if they had poorly controlled diabetes, prior topiramate treatment, recurrent nephrolithiasis, type 1 diabetes, use of insulin within 3 months before screening, history of foot ulceration, planned bariatric surgery, history of alcohol or drug overuse in the 2 years before screening, family history of a hereditary neuropathy, or an alternative neuropathy cause.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Participants received topiramate or matched placebo titrated to a maximum-tolerated dose of 100 mg per day.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>IENFD and NQOL-DN score were co-primary outcome measures. A positive study was defined as efficacy in both or efficacy in one and noninferiority in the other.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 211 individuals were screened, and 132 were randomly assigned to treatment groups: 66 in the topiramate group and 66 in the placebo group. Age and sex were similar between groups (topiramate: mean [SD] age,  61 (10) years; 38 male [58%]; placebo: mean [SD] age, 62 (11) years; 44 male [67%]). The difference in change in IENFD and NQOL-DN score was noninferior but not superior in the intention-to-treat (ITT) analysis (IENFD, 0.21 fibers\/mm per year; 95% CI, \u22120.43 to \u221e fibers\/mm per year and NQOL-DN score, \u22121.52 points per year; 95% CI, \u2212\u221e to 1.19 points per year). A per-protocol analysis excluding noncompliant participants based on serum topiramate levels and those with major protocol deviations demonstrated superiority in NQOL-DN score (\u22123.69 points per year; 95% CI, \u2212\u221e to \u22120.73 points per year). Patients treated with topiramate had a mean (SD) annual change in IENFD of 0.56 fibers\/mm per year relative to placebo (95% CI, \u22120.21 to \u221e fibers\/mm per year). Although IENFD was stable in the topiramate group compared with a decline consistent with expected natural history, this difference did not demonstrate superiority.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion and Relevance<\/jats:title>\n                    <jats:p>Topiramate did not slow IENFD decline or affect NQOL-DN score in the primary ITT analysis. Some participants were intolerant of topiramate. NQOL-DN score was superior among those compliant based on serum levels and without major protocol deviations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT02878798\">NCT02878798<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaneurol.2023.3711","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T11:01:53Z","timestamp":1698058913000},"page":"1334","source":"Crossref","is-referenced-by-count":10,"title":["Safety and Efficacy of Topiramate in Individuals With Cryptogenic Sensory Peripheral Neuropathy With Metabolic Syndrome"],"prefix":"10.1001","volume":"80","author":[{"given":"A. Gordon","family":"Smith","sequence":"first","affiliation":[{"name":"Department of Neurology, Virginia Commonwealth University, Richmond"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Robinson","family":"Singleton","sequence":"additional","affiliation":[{"name":"Department of Neurology, The University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Aperghis","sequence":"additional","affiliation":[{"name":"Department of Neurology, The University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Coffey","sequence":"additional","affiliation":[{"name":"University of Iowa Clinical Trials Statistical and Data Management Center, Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Creigh","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merit","family":"Cudkowicz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Conwit","sequence":"additional","affiliation":[{"name":"Indiana University Department of Neurology and the National Institute of Neurological Disorders and Stroke, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dixie","family":"Ecklund","sequence":"additional","affiliation":[{"name":"University of Iowa Clinical Trials Statistical and Data Management Center, Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janel K.","family":"Fedler","sequence":"additional","affiliation":[{"name":"University of Iowa Clinical Trials Statistical and Data Management Center, Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gudjonsdottir","sequence":"additional","affiliation":[{"name":"University of Iowa Clinical Trials Statistical and Data Management Center, Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hauer","sequence":"additional","affiliation":[{"name":"Department of Neurology, The University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Herrmann","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Kearney","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kissel","sequence":"additional","affiliation":[{"name":"Department of Neurology, Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Klingner","sequence":"additional","affiliation":[{"name":"University of Iowa Clinical Trials Statistical and Data Management Center, Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Quick","sequence":"additional","affiliation":[{"name":"Department of Neurology, Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Revere","sequence":"additional","affiliation":[{"name":"Department of Neurology, The University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amro","family":"Stino","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"NeuroNEXT NN108 TopCSPN Study Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Sirja","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Vinik","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Peltier","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamatha","family":"Pasnoor","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Callaghan","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella Maria","family":"Menichella","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Nance","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Seyedsadiadi","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Saporta","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Phillips","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eroboghene","family":"Ubogu","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Bird","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Geisler","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Lopate","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Caress","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Brannagan","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Gwathmey","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Ortega","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahseen","family":"Mozaffar","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Milstein","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianna","family":"Quan","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Snowden","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Charles","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Wood","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Mountain","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Annis","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Guntrum","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Gibson","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noreen","family":"Connolly","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Behrens-Spraggins","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Doudova","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice","family":"Dolan","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Bartlett","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Agriesti","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Casellini","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bailey","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Lowen","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricia","family":"McKinney","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Furukawa","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Lackey","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Liu","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katheryn","family":"Jennens","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Colgan","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Rasnake","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Stelzer","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Graft","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Ward","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Coffey","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosette","family":"Burian","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Szela","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Houseman","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Casale","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeri","family":"Sieren","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heena","family":"Olalde","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Kressin","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loriane","family":"Brenner","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"James","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Maria","family":"Brito Pires","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Grant","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Levy","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Steele","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Paredes","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Hopkins","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amruta","family":"Joshi","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Thayer","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Conger","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovana","family":"Valdez","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Benge","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Harders","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"Moulton","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengesha","family":"Teshome","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Bauer","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Streckfuss","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summer","family":"Harris","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessyca","family":"Clemons","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karie","family":"Bond","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arreum","family":"Kim","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raisy","family":"Fayerman","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johana","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Moran","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranay","family":"Vissa","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Wilkins","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Turcotte","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Strong","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isela","family":"Hernandez","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Wencel","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Moyer","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Meton","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Slabbekoorn","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehana","family":"Rafi","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Capobianco","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Parido","sequence":"additional","affiliation":[{"name":"for the NeuroNEXT NN108 TopCSPN Study Team"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"18","key":"noi230075r1","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1212\/WNL.0000000000003293","article-title":"Prevalence of polyneuropathy in the general middle-aged and elderly population.","volume":"87","author":"Hanewinckel","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"noi230075r2","doi-asserted-by":"publisher","first-page":"817","DOI":"10.2337\/dc12-0469","article-title":"Chronic idiopathic axonal polyneuropathy is associated with the metabolic syndrome.","volume":"36","author":"Visser","year":"2013","journal-title":"Diabetes Care"},{"issue":"1-2","key":"noi230075r3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jns.2008.06.005","article-title":"Idiopathic neuropathy patients are at high risk for metabolic syndrome.","volume":"273","author":"Smith","year":"2008","journal-title":"J Neurol Sci"},{"issue":"3","key":"noi230075r4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/mus.v63.3","article-title":"Metabolic syndrome and peripheral neuropathy.","volume":"63","author":"Kazamel","year":"2021","journal-title":"Muscle Nerve"},{"issue":"5","key":"noi230075r5","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1212\/01.WNL.0000137341.89781.14","article-title":"Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects.","volume":"63","author":"Raskin","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"noi230075r6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/oby.2011.330","article-title":"Controlled-release phentermine\/topiramate in severely obese adults: a randomized controlled trial (EQUIP).","volume":"20","author":"Allison","year":"2012","journal-title":"Obesity (Silver Spring)"},{"issue":"5","key":"noi230075r7","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1111\/obr.2011.12.issue-5","article-title":"Efficacy and safety of topiramate on weight loss: a meta-analysis of randomized controlled trials.","volume":"12","author":"Kramer","year":"2011","journal-title":"Obes Rev"},{"issue":"3","key":"noi230075r8","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1177\/193229681100500326","article-title":"Quality of life and objective measures of diabetic neuropathy in a prospective placebo-controlled trial of ruboxistaurin and topiramate.","volume":"5","author":"Boyd","year":"2011","journal-title":"J Diabetes Sci Technol"},{"key":"noi230075r9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2147\/DMSO","article-title":"Topiramate improves neurovascular function, epidermal nerve fiber morphology, and metabolism in patients with type 2 diabetes mellitus.","volume":"3","author":"Boyd","year":"2010","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"6","key":"noi230075r10","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1001\/jamaneurol.2020.0367","article-title":"Seven-year experience from the National Institute of Neurological Disorders and Stroke\u2013supported network for excellence in neuroscience clinical trials.","volume":"77","author":"Cudkowicz","year":"2020","journal-title":"JAMA Neurol"},{"issue":"11","key":"noi230075r11","doi-asserted-by":"publisher","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.","volume":"152","author":"Schulz","year":"2010","journal-title":"Ann Intern Med"},{"issue":"10","key":"noi230075r12","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.2337\/dc10-1303","article-title":"Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments.","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diabetes Care"},{"issue":"3","key":"noi230075r13","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"issue":"3","key":"noi230075r14","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/jns.2010.15.issue-3","article-title":"Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study.","volume":"15","author":"Lauria","year":"2010","journal-title":"J Peripher Nerv Syst"},{"issue":"4","key":"noi230075r15","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jpainsymman.2004.06.018","article-title":"Validation of a modified version of the brief pain inventory for painful diabetic peripheral neuropathy.","volume":"29","author":"Zelman","year":"2005","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"noi230075r16","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/jns.2008.13.issue-3","article-title":"The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy.","volume":"13","author":"Singleton","year":"2008","journal-title":"J Peripher Nerv Syst"},{"issue":"8","key":"noi230075r17","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.clinthera.2005.08.002","article-title":"Development and validity testing of the neuropathy total symptom score 6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy.","volume":"27","author":"Bastyr","year":"2005","journal-title":"Clin Ther"},{"issue":"3","key":"noi230075r18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/dia.2005.7.497","article-title":"The development and validation of the Norfolk QOL-DN, a new measure of patients\u2019 perception of the effects of diabetes and diabetic neuropathy.","volume":"7","author":"Vinik","year":"2005","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"noi230075r19","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jdiacomp.2013.04.003","article-title":"Obesity and hyperlipidemia are risk factors for early diabetic neuropathy.","volume":"27","author":"Smith","year":"2013","journal-title":"J Diabetes Complications"},{"key":"noi230075r21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/statistics.2017.4.issue-1","article-title":"Two-part and related regression models for longitudinal data.","volume":"4","author":"Farewell","year":"2017","journal-title":"Annu Rev Stat Appl"},{"issue":"5","key":"noi230075r23","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00125-020-05085-9","article-title":"Diabetic neuropathy: what does the future hold?","volume":"63","author":"Callaghan","year":"2020","journal-title":"Diabetologia"},{"issue":"2","key":"noi230075r24","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1526-4637.2008.00555.x","article-title":"Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA\/KORA Augsburg Surveys S2 and S3.","volume":"10","author":"Ziegler","year":"2009","journal-title":"Pain Med"},{"issue":"10","key":"noi230075r25","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/acn3.125","article-title":"Exercise increases cutaneous nerve density in diabetic patients without neuropathy.","volume":"1","author":"Singleton","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"noi230075r26","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1001\/jamaneurol.2016.0057","article-title":"Longitudinal assessment of small fiber neuropathy: evidence of a non\u2013length-dependent distal axonopathy.","volume":"73","author":"Khoshnoodi","year":"2016","journal-title":"JAMA Neurol"},{"issue":"5","key":"noi230075r27","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jdiacomp.2015.04.001","article-title":"Detection of undisclosed neuropathy and assessment of its impact on quality of life: a survey in 25,000 Romanian patients with diabetes.","volume":"29","author":"Veresiu","year":"2015","journal-title":"J Diabetes Complications"},{"issue":"4","key":"noi230075r28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/ane.2004.110.issue-4","article-title":"Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials.","volume":"110","author":"Thienel","year":"2004","journal-title":"Acta Neurol Scand"},{"key":"noi230075r20","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/978-1-4939-8715-3_39","volume-title":"Health Services Evaluation","author":"Neelon","year":"2019"},{"key":"noi230075r22","unstructured":"The Comprehensive R Archive Network. Package \u201cGLMMadaptive.\u201d Accessed March 10, 2022. https:\/\/cran.r-project.org\/web\/packages\/GLMMadaptive\/GLMMadaptive.pdf"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2810535\/jamaneurology_smith_2023_oi_230075_1702053742.0705.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T11:27:35Z","timestamp":1702294055000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2810535"}},"subtitle":["The TopCSPN Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2023.3711","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,1]]}}}